WebSep 6, 2024 · PR Newswire. ROCKVILLE, Md., Sept. 6, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage … WebMar 15, 2024 · Shuttle Pharmaceuticals Holdings, Inc. ... ("IPO") raising gross proceeds of $11.5 million, inclusive of the overallotment option, listing its common stock on the Nasdaq Capital Market.
Shuttle Pharmaceuticals Announces Closing of Initial Public Offering
WebShuttle Pharmaceuticals is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Our … WebMark is an experienced C-Level professional and the Founder & Chief Visionary Officer at NOUV, a management and financial consulting firm that offers an integrated solution across all business functions in consulting, business support and assurance services. Mark specialises in helping organisations identify, design, and execute their strategy. He has … shaped notes chart
Shuttle Pharmaceuticals announces prici…
WebApr 14, 2024 · KNOT Offshore Partners Stock Performance. The company has a market cap of $169.81 million, a PE ratio of 2.89 and a beta of 0.82. The company has a debt-to-equity ratio of 1.21, a current ratio of ... WebJul 1, 2024 · The last biotech to go public, eye drug developer Okyo Pharma, did so in mid-May and raised less than $3 million, according to BioPharma Dive’s database. Two biotechs, Genelux and Shuttle Pharmaceuticals, have publicly outlined IPO plans since the end of April, and they’ve joined a queue of companies mostly targeting modest offerings. WebAug 30, 2024 · Aug 30, 2024, 16:40 ET. ROCKVILLE, Md., Aug. 30, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH ), a discovery and development … pontoon boat corner storage compartments